VijayPD Ceutical operating cash outflow reaches Rs 25.1368 crore
Key highlights
- VijayPD Ceutical reported a Rs 25.1368 crore net operating cash outflow for the half year ended September 30, 2026.
- Trade receivables increased by Rs 35.9383 crore in the September 2026 cash-flow period.
- Cash and cash equivalents fell to Rs 1.953 crore at September 30, 2026 from Rs 17.5167 crore at the period’s start.
- Profit attributable to owners was Rs 3.3566 crore on revenue from operations of Rs 105.2111 crore in the half year ended September 30, 2026.
powered by IRIS

VijayPD Ceutical Limited recorded a Rs 25.1368 crore net operating cash outflow in the half year ended September 30, 2026, despite Rs 3.3566 crore profit attributable to owners, as trade receivables rose by Rs 35.9383 crore and inventory and loans and advances also absorbed cash. Cash and cash equivalents closed at Rs 1.953 crore.
Know Vijaypd Ceutical inside out
Results, valuation, peers and who's buying, in one view.
Why did VijayPD Ceutical report an operating cash outflow?
VijayPD Ceutical reported net cash used in operating activities of Rs 25.1368 crore for the half year ended September 30, 2026, compared with an outflow of Rs 8.7794 crore in the cash-flow statement column for the year ended March 31, 2026. Operating profit before working-capital changes was positive at Rs 6.3866 crore, but changes in operating assets and liabilities resulted in cash generated from operations of negative Rs 25.3744 crore.
The source labels the document a statement of unaudited consolidated cash flow for the half year ended September 30, 2026, although its two data columns are headed “Year ended 30/09/2026” and “Year ended 31/03/2026”. The September 2026 financial results were unaudited and the March 2026 figures were audited. Direct taxes paid, net of refunds, were Rs 23.76 lakh in the September period, compared with Rs 1.2863 crore in the March period.
The operating result before working-capital movements was lower than Rs 8.6979 crore in the March 2026 cash-flow column. Depreciation and amortisation contributed Rs 44.21 lakh and finance costs added back in the reconciliation were Rs 1.6668 crore, while interest income of Rs 30.07 lakh was deducted from profit before tax of Rs 4.6038 crore.
How did working capital absorb VijayPD Ceutical’s cash?
VijayPD Ceutical’s largest operating cash use was the Rs 35.9383 crore increase in trade receivables, against a Rs 8.0152 crore increase in the March 2026 cash-flow column. Trade receivables on the balance sheet stood at Rs 67.5823 crore on September 30, 2026, compared with Rs 31.644 crore on March 31, 2026.
Inventories absorbed Rs 8.9044 crore, compared with Rs 83.58 lakh in the March period, and the closing inventory balance rose to Rs 21.3679 crore from Rs 12.4635 crore. Loans and advances used a further Rs 15.9228 crore of cash, compared with Rs 10.4283 crore previously. The balance-sheet line for short-term loans and advances increased to Rs 25.9307 crore from Rs 10.0079 crore.
Higher payables partially offset those cash demands. Trade payables generated Rs 27.0211 crore of cash in the September period, versus Rs 6.0604 crore in the March cash-flow column, while other liabilities and provisions contributed Rs 1.9273 crore. Trade payables to creditors other than micro and small enterprises reached Rs 34.7197 crore at September 30, 2026, from Rs 8.0973 crore at March 31, 2026; dues to micro and small enterprises increased to Rs 45.49 lakh from Rs 5.64 lakh.
How did VijayPD Ceutical fund the cash shortfall?
VijayPD Ceutical generated Rs 10.6681 crore from financing activities in the September 2026 period, following operating and investing cash outflows. Net short-term borrowings provided Rs 8.3951 crore and proceeds from long-term borrowings were Rs 4.0268 crore. Finance costs paid used Rs 1.6668 crore, while payments to minority interest were Rs 8.69 lakh.
The balance sheet recorded long-term borrowings of Rs 8.4126 crore at September 30, 2026, up from Rs 4.3858 crore at March 31, 2026. Short-term borrowings rose to Rs 40.7155 crore from Rs 32.3204 crore. Finance cost in the half-year income statement was Rs 1.6668 crore, compared with Rs 1.0612 crore in the half year ended September 30, 2025.
Investing activities used Rs 1.0951 crore in the September period, compared with Rs 4.9818 crore in the March cash-flow column. Purchases of property, plant and equipment and capital work-in-progress totalled Rs 2.7536 crore. That outflow was partly offset by a Rs 1.3413 crore change in long-term loans and Rs 30.07 lakh of interest received.
Got a follow-up? Ask IRIS
How did VijayPD Ceutical remain profitable despite negative operating cash flow?
VijayPD Ceutical reported profit attributable to owners of the parent of Rs 3.3566 crore for the half year ended September 30, 2026, up from Rs 2.4154 crore in the half year ended September 30, 2025. Revenue from operations increased to Rs 105.2111 crore from Rs 51.334 crore, while total expenses rose to Rs 101.0275 crore from Rs 48.3124 crore.
The difference between reported profit and cash flow principally reflects working-capital movements. Profit before tax was Rs 4.6038 crore and depreciation and amortisation added Rs 44.21 lakh in the cash-flow reconciliation. The combined Rs 60.7655 crore cash absorption from receivables, inventory and loans and advances exceeded the Rs 28.9484 crore cash contribution from trade payables and other liabilities and provisions.
The company disclosed a comparability limitation for the September 2025 results. It had no subsidiary in the corresponding half year ended September 30, 2025 or the year ended March 31, 2025, so the comparative consolidated figures for that prior period are standalone results. VijayPD Ceutical said the group is exclusively engaged in pharmaceutical trading and therefore has no separate reportable segment under Accounting Standard 17.
What happened to VijayPD Ceutical’s cash balance and balance sheet?
VijayPD Ceutical’s cash and cash equivalents fell by Rs 15.5638 crore to Rs 1.953 crore at September 30, 2026, from Rs 17.5167 crore at the start of the reported period. The decrease combines the Rs 25.1368 crore operating outflow and Rs 1.0951 crore investing outflow with the Rs 10.6681 crore financing inflow.
Total current assets increased to Rs 116.9177 crore at September 30, 2026, from Rs 76.5831 crore at March 31, 2026, led by receivables, inventories and short-term loans and advances. Total current liabilities rose to Rs 80.6602 crore from Rs 43.3284 crore, including short-term borrowings and trade payables. Shareholders’ funds increased to Rs 55.7333 crore from Rs 52.4057 crore as reserves and surplus rose to Rs 36.3708 crore from Rs 32.9552 crore.
The statutory auditors conducted a limited review of the consolidated half-year results and expressed an unmodified conclusion, according to the company’s notes. VijayPD Ceutical’s board approved the results on November 14, 2026.
Conclusion
VijayPD Ceutical’s reported earnings growth was accompanied by substantially higher balances in receivables, inventory and short-term loans and advances. Higher trade payables and additional borrowing provided partial funding, but they did not prevent a sharp reduction in cash and cash equivalents during the September 2026 period.
The next reporting periods can show whether these working-capital balances are converted into cash and how borrowings develop. VijayPD Ceutical also reported no deviation in use of its Rs 19.25 crore initial public offering proceeds as of September 30, 2026, including Rs 10.8283 crore allocated to a pharmaceutical active pharmaceutical ingredients, intermediates and chemicals manufacturing plant and machinery, and Rs 5.10 crore allocated to repayment or prepayment of borrowings.


